FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to compounds and pharmaceutical compositions based on them for treatment or prevention of a disease associated with Type 2 sodium-glucose cotransporter, and can be used in medicine. Compound of formula (I) is proposed:
wherein R1 represents H, halogen, C1-С6alkyl, C1-С6alkoxy, C2-С6alkynyl, cyano; X is selected from -СН2-, -С(=O)- and -СН(-ОН)-; Ar is selected from substituted or unsubstituted furanyl, thiophenyl, thiazolyl, benzothiophenyl and benzofuranyl; wherein substitution means that one or more hydrogen atoms in the group are replaced by an atom of the group consisting of cyano, C1-С6alkyl, C1-С6alkoxy, halogen, C1-С6haloalkyl, С6aryl or furanyl, thiophenyl, pyridinyl, substituted or unsubstituted by 1-3 substituents.
EFFECT: new compounds effective as an inhibitor of Type 2 sodium glucose cotransporter, pharmaceutical compositions based on them for preparing a pharmaceutical composition for treatment or prevention of a disease associated with Type 2 sodium glucose cotransporter are proposed.
11 cl, 160 ex, 15 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
2-CYANOPYRIMIDINE-4-YL CARBAMATE, OR A UREA DERIVATIVE, OR ITS SALT AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2019 |
|
RU2788740C2 |
PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
NAPHTHYLACETIC ACIDS | 2009 |
|
RU2539185C2 |
FLUORINATED COMPOUND OF CYCLOPROPYLAMINE, THE METHOD OF PREPARATION, THE PHARMACEUTICAL COMPOSITION AND ITS USE | 2017 |
|
RU2746323C2 |
10H-PHENOTHIAZINE FERROPTOSIS INHIBITORS, THEIR PRODUCTION METHOD AND THEIR USE | 2019 |
|
RU2787366C2 |
N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2744358C2 |
N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2722560C1 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
Authors
Dates
2021-04-21—Published
2016-06-23—Filed